About Berkshire Biomedical

"Find a Better Way"


Tommy Rouse is a successful former banker and financial payments industry executive. He's an innovator, visionary, and builder, with a knack for assembling talented management teams. Susan Owen is a successful, dynamic brand creator, and marketing communications executive. Together they formed and personally funded Berkshire Biomedical.

In 2016, Tommy endured three consecutive spinal surgeries; the procedures and post-operative care went well, but the longer-term home recovery was unnecessarily difficult and prolonged. His pain became unmanageable as he struggled to properly self-administer his medications and provide accurate adherence information to his doctor. Tommy was frustrated by his delayed recovery and became concerned as he learned of the increasing impacts on society of misuse and abuse of prescription drugs. Determined to find a better way, he called upon his long-time friend Susan, to brainstorm his idea for a solution.

The idea was to develop an easy to use, connected and data-driven medication delivery system to address the challenges and achieve their goal. They built a team of trusted and seasoned professionals and advisory board members with executive level backgrounds in healthcare, and extensive experience in early stage investing and product development in the med-tech and biotech industries. In addition, Berkshire has partnered with world class engineers, FDA regulatory advisors, and trademark and patent attorneys to support the business.

Founders and Management:

Thomas M. Rouse
Founder & Chairman

  • Commercial Banker / Private Equity / Serial Entrepreneur
  • Chief Executive Officer TransFirst, RSquared Capital
  • Executive Vice President – MTech, ACS

Susan Owen
Co-Founder & Vice Chairman

  • Strategist, Investor & Entrepreneur, YPO-Board Member
  • Former President & Chief Operating Officer – The Point Group
  • Commercial Banking Industry – Diverse Positions and Financial Institutions

John E. Timberlake
President and Chief Executive Officer
Board Member

  • 30+ years of healthcare executive leadership with accomplished track-record commercializing medical devices, drugs, and drug-device combinations
  • Progressive leadership at private, public, small start-up to multibillion-dollar organizations in the Medical Technology and Pharmaceutical industries
  • CEO of private and public companies with extensive board management and capital raising experience in the private and public markets

Christy Corey
Chief Operating Officer

  • 25-year Fin-Tech Executive
  • Multi-Discipline Integration, Implementation, Product and Project Management Specialist
  • Healthcare Management System Integration & Work Flow Expertise

John Kirkpatrick
Chief Technology Officer

  • 30+ years leadership experience developing and implementing complex global business strategies for companies of all sizes
  • Held multiple executive roles at healthcare companies with global responsibilities and has broad experience in IT M&A, software engineering, business intelligence, corporate governance, data center operations, e-commerce and product development

Geoff Jenkins

Advisory Board Member

Tom King

Advisory Board Member

Lee Moffitt, JD

Advisory Board Member

Colonel (ret) Geoffrey Ling, M.D., Ph.D.

Advisory Board Member

Here is a link to Berkshire Biomedical’s Financial Conflict of Interest Policy (FCOI).